Made by Eli Lilly, its technically a dual agonist because it activates both GLP-1 and GIP receptors rather than just GLP-1 alone
In clinical trials, liraglutide showed a placebo-corrected weight loss of around 5%, semaglutide 12%, and tirzepatide 18% [23]
The SURMOUNT trials demonstrated average weight loss of 20 to 25 percent of body weight, numbers that exceeded anything previously seen with pharmaceutical interventions
Experimental weight loss drug retatrutide shows dramatic weight loss in clinical trial Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical trial results released on Thursday
Brand-name Mounjaro offers FDA approval, clinical trial validation, consistent manufacturing standards, and pre-filled pen convenience
Exposure of RAW 264.7 cells to LPS for four hours dramatically increased the secretion of IL-6 to 613.2 35.1 pg/ml and TNF- to 1556.3 23.3 pg/ml